Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
Abstract 149Tb represents a powerful alternative to currently used α-emitters: the relatively short half-life (T1/2 = 4.1 h), low α-energy (3.97 MeV, Iα = 16.7 %), absence of α-emitting daughters and stable coordination via DOTA are favorable features for potential clinical application. In this lett...
Saved in:
Main Authors: | Cristina Müller (Author), Christiaan Vermeulen (Author), Ulli Köster (Author), Karl Johnston (Author), Andreas Türler (Author), Roger Schibli (Author), Nicholas P. van der Meulen (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
by: Cristina Müller, et al.
Published: (2014) -
47Sc as useful β--emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
by: Katharina A. Domnanich, et al.
Published: (2017) -
Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging
by: C. Favaretto, et al.
Published: (2021) -
Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy
by: Nadezda Gracheva, et al.
Published: (2019) -
44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
by: Katharina A. Domnanich, et al.
Published: (2016)